Modeling preventative strategies against human papillomavirus-related disease in developed countries
K Canfell, H Chesson, SL Kulasingam, J Berkhof… - Vaccine, 2012 - Elsevier
Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-
adolescent females has been introduced in most developed countries, supported by …
adolescent females has been introduced in most developed countries, supported by …
Adolescent and young adult HPV vaccination in Australia: achievements and challenges
Australia commenced an ongoing school based government funded human
papillomaviruses (HPV)(cervical cancer prevention) vaccination program in April 2007 for …
papillomaviruses (HPV)(cervical cancer prevention) vaccination program in April 2007 for …
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment …
Summary Background Australia's National Cervical Screening Program currently
recommends cytological screening every 2 years for women aged 18–69 years. Human …
recommends cytological screening every 2 years for women aged 18–69 years. Human …
[HTML][HTML] The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC …
HC Kitchener, K Canfell, C Gilham… - Health Technology …, 2014 - ncbi.nlm.nih.gov
BACKGROUND The ARTISTIC (A Randomised Trial In Screening To Improve Cytology) trial
originally reported after two rounds of primary cervical screening with human papillomavirus …
originally reported after two rounds of primary cervical screening with human papillomavirus …
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: example from Australia
Background Many countries are transitioning from cytology-based to longer-interval HPV
screening. Trials comparing HPV-based screening to cytology report an increase in CIN2/3 …
screening. Trials comparing HPV-based screening to cytology report an increase in CIN2/3 …
Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis
Background: Cervical screening on self-collected samples has mainly been considered for
targeted use in underscreened women. Updated evidence supports equivalent sensitivity of …
targeted use in underscreened women. Updated evidence supports equivalent sensitivity of …
Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand
Background New Zealand (NZ) is considering transitioning from 3-yearly cervical cytology
screening in women 20–69 years (current practice) to primary HPV screening. We evaluated …
screening in women 20–69 years (current practice) to primary HPV screening. We evaluated …
Will cervical screening remain cost‐effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
A next generation nonavalent human papillomavirus (HPV) vaccine (“HPV9 vaccine”) is
being introduced in several countries. The aims of this study were to evaluate whether …
being introduced in several countries. The aims of this study were to evaluate whether …
Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening
WK Huh, E Williams, J Huang, T Bramley… - … health economics and …, 2015 - Springer
Background There is limited understanding of the health economic implications of cervical
screening with human papillomavirus (HPV)-16/18 genotyping. Objective The aim of this …
screening with human papillomavirus (HPV)-16/18 genotyping. Objective The aim of this …
Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years
PH Sykes, BJ Simcock, CR Innes, D Harker… - American Journal of …, 2022 - Elsevier
Background A number of retrospective and prospective studies have documented
substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young …
substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young …